GlassScriptPhysician profile
Darin Ryan Goldman
NPI 1861699290
$6,052.06
in general payments reported to CMS, 2019-2025
23 companies · $782 in 2025
The $782 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,629 · 2020: $18.27 · 2021: $473 · 2022: $958 · 2023: $1,402 · 2024: $790 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,974.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $1,449.92 | 2019-2025 | Vabysmo, Susvimo, Lunsumio |
| Regeneron Healthcare Solutions, INC. | $1,311.04 | 2019-2025 | Eylea, Eylea Hd |
| Apellis Pharmaceuticals, INC. | $457.61 | 2022-2025 | Syfovre |
| Regeneron Pharmaceuticals, INC. | $362.61 | 2019-2024 | Eylea, Eylea Hd |
| Novartis Pharmaceuticals Corporation | $321.91 | 2019 | |
| Rayner Intraocular Lenses Limited | $249.98 | 2023-2024 | Rayone Aspheric, Rayone Emv, Omidria |
| Coherus Oncology, INC. | $220.08 | 2022-2024 | |
| Astellas Pharma US INC | $151.00 | 2024-2025 | Izervay |
| Alcon Vision LLC | $143.52 | 2021-2025 | Unity |
| Omeros Corporation | $125.00 | 2019 | |
| Dutch Ophthalmic, USA | $125.00 | 2023 | Eva, Combined Machine, Tissueblue |
| Bausch & Lomb Americas INC. | $125.00 | 2024 | Vyzulta |
| Kala Pharmaceuticals, INC. | $122.07 | 2019 | |
| Biotissue Holdings INC. | $120.07 | 2022 | |
| Mallinckrodt Hospital Products INC. | $107.29 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $106.76 | 2021 | |
| Spark Therapeutics, INC. | $105.68 | 2019 | |
| Aerie Pharmaceuticals, INC. | $105.11 | 2019 | |
| Dompe US, INC. | $102.57 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $98.77 | 2021 | |
| Sight Sciences, INC. | $89.96 | 2019 | |
| Sandoz INC. | $31.02 | 2024 | Cimerli |
| Viiv Healthcare Company | $20.09 | 2024 | Cabenuva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darin Goldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.